Essayer OR - Gratuit
LUB raises concerns & demands related to pharma industry
Chronicle Pharmabiz
|July 24, 2025
LAGHU Udyog Bharati (LUB), the association representing micro and small industries in the country, has said that it is pursuing various matters related to the micro, small and medium enterprises (MSME) in pharma sector with the Union health ministry and the ministry of chemicals and fertilisers.

The leaders of LUB, including All India president Ghanshyam Ojha, All India general secretary Omprakash Gupta, All India Head of LUB's Pharma Wing Dr Rajesh Gupta, Maharashtra pharma wing head Dr Ravleen khurana, Madhya Pradesh pharma wing Head Amit Chawla, along with other industry representatives have met the Union minister of chemicals and fertilisers and health and welfare, J P Nadda and raised various demands of the industry, it said.
The leaders raised concerns regarding the extension of deadline for implementation of revised Schedule M, which is critical for the survival of the MSME pharma companies below Rs. 50 crore turnover. An extension of deadline would prevent closure of large number of micro and small companies.
Cette histoire est tirée de l'édition July 24, 2025 de Chronicle Pharmabiz.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Chronicle Pharmabiz
Chronicle Pharmabiz
Miltenyi Biotec, THSTI to set up cell mfg programme
IN a milestone step toward strengthening India's cell and gene therapy (CGT) ecosystem, Miltenyi Biotec, a global leader in CGT technologies, has signed a Letter of Intent (LOI) with the Translational Health Science and Technology Institute (THSTI) to establish India's first hands-on training programmes in clinical cell manufacturing.
1 min
August 21, 2025
Chronicle Pharmabiz
MDC asks Abbott Healthcare to avoid negligence while filing price details
THE Multi Disciplinary Committee (MDC) of Experts, which advises the National Pharmaceutical Pricing Authority (NPPA) on pricing matters, has directed Abbott Healthcare to avoid negligence in filing proper details while submitting the price related details in the Integrated Pharmaceutical Database Management System (IPDMS).
1 mins
August 21, 2025
Chronicle Pharmabiz
Greenspace Herbs unveils 'Quantum Ayurveda'
GREENSPACE Herbs, a leading botanical ingredients company, announced the commercial launch of Quantum Ayurveda, an advanced technology platform that enhances traditional herbal ingredients using quantum resonance principles.
1 min
August 21, 2025

Chronicle Pharmabiz
Gandhi Automations ensuring clean room integrity with high-speed doors
GANDHI Automations Pvt Ltd offers prime clean reset high-speed doors to ensure clean room integrity, minimize air permeability and leakages.
3 mins
August 21, 2025
Chronicle Pharmabiz
Haryana DC officials raid unregistered clinic in Karnal
In a swift response to a complaint regarding illegal medical practice, a team of health and drug control officials raided an unregistered clinic in Karnal in Haryana, leading to the arrest of an individual found to be practicing medicine without proper medical qualification.
1 min
August 21, 2025
Chronicle Pharmabiz
Guj attracts investments from 100 cr to 5,000 cr
GUJARAT has attracted big ticket investments from MNCs and Indian companies as part of 376 Memorandum of Understandings (MoUs) ranging from Rs. 100 crore to Rs. 5,000 crore, informed Dr H G Koshia, Commissioner of the Gujarat Food & Drug Control Administration (FDCA).
1 min
August 21, 2025
Chronicle Pharmabiz
'Industry's diversification to EU markets is acting as a buffer against US trade shocks'
INDIAN Pharma industry's diversification into European markets is acting as a buffer against US trade shocks, says Parag Bhatia, director, Laborate Pharmaceuticals.
2 mins
August 21, 2025
Chronicle Pharmabiz
Pharma, CROs turn to hybrid cloud infra to safeguard patient information
PHARMA companies and clinical research organizations (CROs) are increasingly adopting hybrid cloud infrastructure to safeguard sensitive patient information.
2 mins
August 21, 2025
Chronicle Pharmabiz
'India's PLI scheme transforms pharma industry from policy to practice'
INDIA'S production linked incentive (PLI) scheme has emerged as a transformative policy aimed at revitalizing the pharmaceutical sector and its global competitiveness.
2 mins
August 21, 2025
Chronicle Pharmabiz
CDSCO cancels Proteos' Indian agent's import regn
THE Cosmetics Division of the Central Drugs Standard Control Organisation (CDSCO) has cancelled the registration certificate of NKG Advisory Business and Consulting Services to sell the cosmetic products of Spanish cosmetics maker Proteos Biotech, based on the former's request.
1 min
August 21, 2025
Listen
Translate
Change font size